C151 (Lamotrigine 150 mg)
Pill with imprint C151 is Pink, Capsule-shape and has been identified as Lamotrigine 150 mg. It is supplied by Cipla Limited.
Lamotrigine is used in the treatment of bipolar disorder; schizoaffective disorder; seizure prevention; epilepsy and belongs to the drug class triazine anticonvulsants. Risk cannot be ruled out during pregnancy. Lamotrigine 150 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for C151
Lamotrigine
- Imprint
- C151
- Strength
- 150 mg
- Color
- Pink
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Triazine anticonvulsants
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Cipla Limited
- National Drug Code (NDC)
- 69097-0151 (Discontinued)
- Inactive Ingredients
-
lactose monohydrate,
sodium starch glycolate type A potato,
silicon dioxide,
povidone k30,
magnesium stearate,
ferric oxide red,
ferric oxide yellow,
ferrosoferric oxide
Note: Inactive ingredients may vary.
Related images for "C151"
More about lamotrigine
- Side effects
- Drug interactions
- Dosage information
- During pregnancy or Breastfeeding
- Reviews (1,552)
- Patient tips
- Drug images
- Compare alternatives
- Pricing & coupons
- En español
- Drug class: triazine anticonvulsants
Patient resources
- Drug Information
- Lamotrigine Extended-Release Tablets
- Lamotrigine Tablets
- Lamotrigine Chewable Dispersible Tablets
- Lamotrigine Orally Disintegrating Tablets
Other brands
Lamictal, Lamictal XR, Lamictal ODT, Subvenite, Lamictal CD
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.